Clinical Trial

Renal Denervation in Patients With Chronic Heart Failure With Preserved Ejection Fraction

Study acronym: RDN-HFPEF
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 1, 2024 (before its estimated September 1, 2024 completion). Its status may not reflect the trial's current state.
Summary
This study aims to explore the potential of RDN as a therapy for HFpEF in a Prospective, Multicenter, Randomized, Blinded, Sham-controlled Study.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-02-06.
Status change: Not Yet Recruiting → Recruiting 2024-01-30
Trial Details
NCT Number NCT05715697
Lead Sponsor Xinjiang Medical University
Collaborators: First Affiliated Hospital of Xinjiang Medical University
Conditions Heart Failure With Preserved Ejection Fraction, Renal Denervation
Enrollment 200 participants
Start Date 2023-09-01
Primary Completion 2024-09-01 (estimated)
Study Completion 2026-09-01 (estimated)
Updated on ClinicalTrials.gov 2024-02-01